VP, Clinical Affairs & Patient Safety

Location: Remote GA

Reporting directly to the Chief Medical Officer, the Vice President of Clinical Affairs & Patient Safety is an executive leadership role serving as the authoritative clinical voice across NextGen Healthcare.

This leader drives clinical efficacy, product safety, and human-centered design across our health IT portfolio through two core strategic pillars:

Clinical Center of Excellence (CCoE) Leadership: Direct, mentor, and scale a team of clinicians and healthcare specialists who serve as embedded clinical leads, infusing real-world workflow insights and evidence-based medicine throughout the entire product development lifecycle—from early concept through implementation and commercialization.

Enterprise Patient Safety & Governance: Serve or provide direct executive oversight to the designated enterprise Patient Safety Officer and Chair of the Patient Safety Committee. Direct the Critical Issue Dispositioning (CID) program to ensure rigorous clinical risk triage, close cross-functional collaboration with R&D on root cause analyses, and transparent clinical governance.

Strategic Clinical Leadership & Product Partnership

Lead & Scale the Clinical Center of Excellence (CCoE): Direct, mentor, and expand a high-performing, multidisciplinary team of licensed clinicians (advanced practice providers, nurses, and clinical specialists) who serve as primary clinical subject matter and workflow experts across enterprise initiatives.

Drive Clinical Integration Across the Lifecycle: Champion the integration of evidence-based clinical insights into product roadmap planning, user-centered design, architecture, implementation, and commercialization strategies in close partnership with Product Management and Engineering leadership.

Evaluate Clinical & Tech Innovation: Identify, evaluate, and provide executive guidance on emerging clinical methodologies, health IT standards, and advanced technologies (e.g., ambient clinical intelligence, AI/ML clinical decision support) to maintain competitive advantage and clinical efficacy.